RNA, 7SL, cytoplasmic 280, pseudogene (RN7SL280P)

RNA, 7SL, cytoplasmic 280, pseudogene (RN7SL280P) is classified as a pseudogene in the human genome[1][4]. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; in this case, RN7SL280P is related to 7SL RNA, a key component of the signal recognition particle (SRP), which is essential for targeting secretory proteins to the endoplasmic reticulum during translation[7][8]. However, the RN7SL280P locus itself is a truncated, non-expressed version of the functional gene and is not known to encode functional RNA or protein, nor does it participate directly in biological processes or serve as a therapeutic target[1][5][6]. The vast majority of 7SL pseudogenes, including RN7SL280P, arise from reverse transcription and genomic integration, but they do not have known functional or disease relevance[5][6]. No drugs, biomarkers, or therapeutic mechanisms are associated with this locus, and its annotation is limited to genomic cataloging as a noncoding pseudogene. Notes on accuracy and completeness: - This entry is not considered a therapeutic target; it is a pseudogene and does not encode a functional receptor, enzyme, transporter, or other druggable protein[1][5][6]. - There is no evidence of disease involvement, drug interactions, or biomarker utility for RN7SL280P. - The target provided is potentially misleading: it is not a protein or functional RNA but a pseudogene, so it should not appear as a target in therapeutic contexts[1][5][6]. Summary of key issues: - Proper canonical name and abbreviation provided. - Not a therapeutic target; classification should be "Other" (pseudogene, non-protein-coding). - Should be flagged as "is_incorrect: true" because it is not a true target for drug discovery or biomedical applications.

Other names

RN7SL280PRNA, 7SL, cytoplasmic 280, pseudogene